Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returned 5.43% in the quarter compared to a 6.90% return for the Russell Midcap Growth Index. For the full year, the fund […]

Insulet achieved another remarkable fiscal year, driven by the successful adoption of Omnipod 5, which is being used by growing diabetic patients globally. Read more here.

Tesla (TSLA), Roku (ROKU), Qualtrics (XM) and Insulet (PODD) are among the stocks to watch on Monday.

Stock in insulin delivery system maker Insulet (PODD) is a key Friday-evening beneficiary of a bank failure - as it jumps 7.7% postmarket on word that it''s joining the S&P 500

S&P Indices said late Friday that Insulet Corp. PODD will replace Silicon Valley Bank parent SVB Financial Group SIVB in the S&P 500 index SPX at the open on Wednesday. The bank was shut down Friday by regulators. Insulet is medical device company based in Massachusetts. Insulet stock rallied 7% in the extended session after ending the regular trading day down 1%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy outperformed the Russell 2500 Growth benchmark. On an absolute basis, the strategy gained in nine of the 10 sectors it was invested in […]

Insulet Corporation (NASDAQ:NASDAQ:PODD) Q4 2022 Results Conference Call February 23, 2023 4:30 PM ETCompany ParticipantsDeborah Gordon - VP, IR Jim Hollingshead - President, CEOWayde…

Represents 7th Consecutive Year of 20% or More Constant Currency Revenue Growth ACTON, Mass.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: INSULET REPORTS FULL YEAR 2022 REVENUE INCREASE OF 19% (22% CONSTANT CURRENCY1) AND FOURTH QUARTER 2022 REVENUE INCREASE OF 20% YEAR-OVER-YEAR (23% CONSTANT CURRENCY) […] The post CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (23% constant currency) appeared first on Fintech News .

ACTON, Mass. (AP) — ACTON, Mass. (AP) — Insulet Corp. (PODD) on Thursday reported fourth-quarter net income of $17 million.…

Insulet press release (PODD): Q4 Non-GAAP EPS of $0.55 beats by $0.36.Revenue of $369.7M (+20.1% Y/Y) beats by $37.97M.Adjusted EBITDA of $71.4 million, or 19.3% of revenue, compared…

https://www.investing.com/news/pro/insulet-lower-on-apple-headlines-432SI-3010908

Insulet (NASDAQ: PODD ) is set to give its latest quarterly earnings report on Thursday, 2023-02-23. Here''s what investors need to know before the announcement. Analysts estimate that Insulet will report an earnings per share (EPS) of $0.21. Insulet bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the presentation of new real-world evidence related to the Omnipod 5 Automated Insulin Delivery System at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) taking place February 22 – 25, 2023

Insulet Corporation has been a long-term steady growth play in the diabetes delivery space. Its Omnipod 5 is popular. Is PODD stock a buy? Click here to find out.

Insulet (PODD) said it acquired the assets of Automated Glucose Control ((AGC)).Palo Alto, Calif.-based AGC is focused on developing and selling automated insulin delivery technology

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at two upcoming investor conferences: The Raymond James & Associates 44th Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 7, 2023 at 9:15 a.m. (Eastern Time) The Cowen 43rd Annual Health Care Conference in Boston, MA on Wednesday, March 8, 2023 at 10:30 a

Insulet (Nasdaq:PODD) announced today that it acquired assets related to Bigfoot Biomedical’s pump-based automated insulin delivery technologies. Acton, Massachusetts-based Insulet paid $25 million to acquire the AID assets. These include certain Bigfoot patents related to pumps that may be used for AID therapy. Insulet already develops its own AID technology with its Omnipod platform. The […] The post Insulet acquires insulin pump patents from Bigfoot Biomedical for $25M appeared first on Drug Delivery Business .

Medical device company Insulet (PODD) has acquired assets related to Bigfoot Biomedical''s pump-based automated insulin delivery ((AID)) technologies for $25M.The acquisition…

ACTON, Mass. & MILPITAS, Calif.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced Insulet has acquired assets related to Bigfoot’s pump-based automated insulin delivery (AID) technologies. Insulet paid $25M for the acquisition, which includes certain Bigfoot patents relat

Tech stocks continue to be a major player in the stock market in 2023. Driven by ongoing innovation and investment, big-name turnarounds suggest that Feb. could be the beginning of a sharp upward trend for tech stocks. In fact, here are seven of the best tech stocks to consider for the year. PI Impinj $126.80 META Meta Platforms $178.17 PODD Insulet Corporation $286.67 MSFT Microsoft $264.03 STX Seagate Technology $69.43 CRM Salesforce $172.56 NFLX Netflix $362.79 Best Tech Stocks: Impinj (PI) Source: Shutterstock Impinj (NASDAQ: PI ) is a technology company specializing in providing solutions for the Internet of Things (IoT). Its products and services include radio-frequency identification (RFID) systems and software. Impinj’s tracking chips connect items and devices to the cloud. The RFID technology that underpins its products and services are especially useful for retail, logistics, and transportation sector firms that need to track physical assets for analytical and other purposes.